Palatin reports Q3 EPS (53c), consensus (50c)
PremiumThe FlyPalatin reports Q3 EPS (53c), consensus (50c)
2M ago
Is PTN a Buy, Before Earnings?
PremiumPre-Earnings
Is PTN a Buy, Before Earnings?
2M ago
Palatin’s IND application for obesity candidate granted FDA clearance
PremiumThe Fly
Palatin’s IND application for obesity candidate granted FDA clearance
3M ago
Palatin price target lowered to $17 from $70 at H.C. Wainwright
PremiumThe FlyPalatin price target lowered to $17 from $70 at H.C. Wainwright
5M ago
Palatin announces results from PL9643 MELODY-1 pivotal Phase 3 clinical trial
PremiumThe Fly
Palatin announces results from PL9643 MELODY-1 pivotal Phase 3 clinical trial
5M ago
Palatin reports Q2 EPS (56c), consensus (20c)
PremiumThe Fly
Palatin reports Q2 EPS (56c), consensus (20c)
5M ago
Palatin Technologies Announces Offering Closure and Vyleesi Sale
PremiumCompany AnnouncementsPalatin Technologies Announces Offering Closure and Vyleesi Sale
6M ago
Palatin Technologies Issues Unregistered Equity Securities Warrants
PremiumCompany Announcements
Palatin Technologies Issues Unregistered Equity Securities Warrants
6M ago
Palatin Technologies Strikes Deal for $9.2M Capital Boost
PremiumCompany Announcements
Palatin Technologies Strikes Deal for $9.2M Capital Boost
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100